Fermenta Biotech MD, chairman and AGM
NSE: FERMENTABSE: 506414Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹439.10.
30 Oct: open ₹439.00, high ₹440.75, low ₹411.30
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,229 Cr1,508th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.03
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.90%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.27
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 42,29254.6% delivered
Fermenta Biotech's chairperson is PRADEEP M CHANDAN and its managing director PRASHANT PRABHAKAR NAGRE, as filed for the quarter to Sep 2026. Its latest annual general meeting was on 11 Aug 2026.
Fermenta Biotech board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonPRADEEP M CHANDAN
- Managing directorPRASHANT PRABHAKAR NAGRE
- Company Secretary and Compliance OfficerVaradvinayak Khambete
9 directors4 independent4 executive1 non-executive
- KRISHNA VASANTKUMAR DATLAExecutive · joined May 2010 · reappointed May 2024 · 1 listed board · 1 committee seat
- ANUPAMA DATLA DESAIExecutive · joined Sep 2019 · reappointed Sep 2025 · 1 listed board
- RAJESHWARI DATLANon-executive · joined Jul 2005 · reappointed Aug 2026 · 1 listed board
- SATISH VARMA AZAD NADIMPALLYExecutive · joined Jul 2003 · reappointed Sep 2025 · 1 listed board · 1 committee seat
- PRAMOD KASATIndependent · joined Aug 2022 · reappointed Aug 2022 · 49 months as independent · 6 listed boards · 5 as independent · 7 committee seats, 1 as chair
- PRADEEP M CHANDAN · ChairpersonIndependent · joined Feb 2024 · reappointed Feb 2024 · 31 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
- RAMANAND MUNDKURIndependent · joined Nov 2024 · reappointed Nov 2024 · 22 months as independent · 1 listed board · 1 as independent · 1 committee seat
- RAJASHRI OJHAIndependent · joined Apr 2020 · reappointed Apr 2025 · 78 months as independent · 1 listed board · 1 as independent · 1 committee seat
- PRASHANT PRABHAKAR NAGRE · Managing directorExecutive · joined May 2021 · reappointed May 2024 · 1 listed board · 1 committee seat
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 11 Aug 20268 of 9 present4 independent · 35 days in between
- 6 Jul 20268 of 9 present4 independent · 40 days in between
- 26 May 20269 of 9 present4 independent
Audit Committee
Chair PRAMOD KASAT
RAMANAND MUNDKUR, RAJASHRI OJHA, PRASHANT PRABHAKAR NAGRE
- 11 Aug 20264 of 4 present3 independent · 35 days in between
- 6 Jul 20264 of 4 present3 independent · 40 days in between
- 26 May 20264 of 4 present3 independent
Nomination and remuneration committee
Chair PRAMOD KASAT
RAJESHWARI DATLA, RAJASHRI OJHA
No meeting listed in the filing.
Stakeholders Relationship Committee
Chair PRADEEP M CHANDAN
SATISH VARMA AZAD NADIMPALLY, PRAMOD KASAT, KRISHNA VASANTKUMAR DATLA
- 11 Aug 20264 of 4 present2 independent · 76 days in between
- 26 May 20264 of 4 present2 independent
Risk Management Committee
Chair RAJASHRI OJHA
SATISH VARMA AZAD NADIMPALLY, ANUPAMA DATLA DESAI, PRASHANT PRABHAKAR NAGRE
No meeting listed in the filing.
Corporate Social Responsibility Committee
Chair RAMANAND MUNDKUR
RAJASHRI OJHA, RAJESHWARI DATLA, KRISHNA VASANTKUMAR DATLA
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Jun 2026.
- S R B C & CO LLPPeer-review certificate valid to Feb 2029
1 earlier auditor
- S R B C CO. LLPNamed in filings from Jun 2025 to Dec 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Fermenta Biotech AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Fermenta Biotech dividend history
Annual general meeting, 11 Aug 2026
15,417 shareholders on the register on 5 Aug 2026; present: 2 promoters and 62 others; votes counted by V N DEODHAR / V.N. DEODHAR & CO., COMPANY SECRETARIES.
To receive, consider and adopt: (a) the audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, Reports of the Board of Directors, and the Auditors thereon; and (b) the audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, and the Report of the Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 70.56% · promoters 100.00% · institutions 4.81% · other public 18.18%
- To declare dividend of Rs. 3.75 (Rupees Three and Paise Seventy-Five only) per equity share having face value of Rs. 5 each (75%) for the financial year ended March 31, 2026.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 70.56% · promoters 100.00% · institutions 4.81% · other public 18.18%
- To appoint a director in place of Ms. Rajeshwari Datla (DIN – 00046864), who retires by rotation and being eligible, offers herself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 70.56% · promoters 100.00% · institutions 4.81% · other public 18.18%
- To approve the continuation of Ms. Rajeshwari Datla (DIN: 00046864) as a Non-Executive Director.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 70.56% · promoters 100.00% · institutions 4.81% · other public 18.18%
- Ratification of remuneration of Cost Auditor of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 70.56% · promoters 100.00% · institutions 4.81% · other public 18.18%
- Approval for Material Related Party Transactions.Ordinary99.98% for0.02% against
Against: promoters 0.00% · institutions 6.80% · other public 0.00%
Turnout: all 5.85% · promoters 0.00% · institutions 4.81% · other public 16.43%
- Commission to Non-Executive DirectorsSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 70.56% · promoters 100.00% · institutions 4.81% · other public 18.18%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.
Mutual fund votes, meeting of 11 Aug 2026, 2 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
To receive, consider and adopt: (a) the audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, Reports of the Board of Directors, and the Auditors thereon; and (b) the audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, and the Report of the Auditors thereon.MoreLess
2 for0 against- To declare dividend of Rs. 3.75 (Rupees Three and Paise Seventy-Five only) per equity share having face value of Rs. 5 each (75%) for the financial year ended March 31, 2026.2 for0 against
- To appoint a director in place of Ms. Rajeshwari Datla (DIN – 00046864), who retires by rotation and being eligible, offers herself for re-appointment.2 for0 against
- To approve the continuation of Ms. Rajeshwari Datla (DIN: 00046864) as a Non-Executive Director.2 for0 against
- Ratification of remuneration of Cost Auditor of the Company.2 for0 against
- Commission to Non-Executive Directors2 for0 against
1 proposal not matched to one resolution
To enter into new contract(s)/ arrangement(s)/transaction(s) (whether by way of an individual transaction or transactions taken together or series of transactions or otherwise), between the Company and Fermenta USA LLC, a step-down subsidiary of the Company (FUSA), for an aggregate value not exceeding Rs. 100 crores, and in the ordinary course of business, as may be agreed upon between the Company (including the Board of Directors, its committees or any person authorised by the Board) and FUSA from time to time.MoreLess
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: The Company has not adequately disclosed the Basis for Arm’s Length pricing. Such disclosures are essential for shareholders to assess whether the transactions are being conducted in fair manner.
0 for2 against
Mutual fund votes, meeting of 2 Sep 2022, 1 fund house
Composite Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited (DVK or Transfaror Company 1) and Aegean Propertias Limited (APL or Transferor Company 2) and Femnenta Biotech Limited (FRL or Transferée Company) and their respective Shareholders.MoreLess
1 for0 against
Mutual fund votes, meeting of 12 Aug 2022, 1 fund house
9 proposals
Appointment of Mr. Pramod Kasat (DIN: 00819790) as an Independent Director of the Company, not liable to retire by rotation, to hold office for a first term of 5 (five) consecutive years with effect from August 12, 2022.MoreLess
1 for0 againstAppointment of S R B C & Co. LLP, Chartered Accountants (ICAI Firm Registration No: 324982E/ E300003) as Statutory Auditors of the Company to hold office for a term of 5 (five) years from the conclusion of 70th Annual General Meeting (AGM) till the conclusion of 75th AGM, in place of the outgoing Auditors, Deloitte Haskins & Sells. LLP, Chartered Accountants (Firm Registration no. 117366W/W-100018), on such remuneration.MoreLess
1 for0 against- Approval for Material Related Party Transaction with Fermenta USA LLC for an aggregate Rs.40,00,00,000 for a period upto next annual general meeting to be held in the year 2023.1 for0 against
Ratification of Remuneration of Rs.2,75,000 plus taxes as applicable and reimbursement of out of pocket expenses paid to M/s Joshi Apte & Associates, Cost Accountants (Firm Registration Number – 00240) as a cost auditor of company for the financial year ending on March 31, 2023.MoreLess
1 for0 againstRe-appointment of Mr. Satish Varma (DIN: 00003255) as an Executive Director and Key Managerial Person of the Company for a period of 3 (three) years commencing from September 27, 2022 to September 26, 2025 and including remuneration.MoreLess
1 for0 againstRe-appointment of Ms. Anupama Datla Desai (DIN: 00217027) as an Executive Director and Key Managerial Person of the Company for a period of 3 (three) years commencing from September 27, 2022 to September 26, 2025 and including remuneration.MoreLess
1 for0 against- To appoint a Director in place of Ms. Anupama Datla Desai (DIN – 00217027), who retires by rotation and, being eligible, offers herself for re-appointment.1 for0 against
- To declare dividend of Rs.1.25 per equity share of Rs.5 each for the financial year ended March 31, 2022.1 for0 against
To receive, consider and adopt: (a) The audited Standalone Financial Statements of the Company for the financial year ended March 31, 2022, Reports of the Board of Directors, and the Auditors thereon; and (b) The audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2022, and the Report of the Auditors thereon.MoreLess
1 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Tax disputes and stakes in unlisted companies
Reported in the filing for the quarter to Sep 2026.
- Unlisted stake boughtFERMENTA ENVIRONMENT SOLUTIONS PRIVATE LIMITEDSince 28 Jul 2025
−8.24% bought in the quarter; holding 91.76%, from 100.00%
- Tax disputeThe Assistant Commissioner, Mandi-I, Central Zone, Himachal Pradesh - 175001Since 26 Mar 2026Status quo remain same
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it.